Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==June 2025== | ==June 2025== | ||
; [[PACIFIC]]: New summary #518: Durvalumab vs. placebo as consolidation in NSCLC | |||
; [[ARIC A1c and CKD]]: New summary #517: HbA1c and CKD risk in DM | ; [[ARIC A1c and CKD]]: New summary #517: HbA1c and CKD risk in DM | ||